Is Centrifuge a Good Investment?
| TVL | $1.4B |
| FDV | $190M |
| TVL/FDV | 7.36x |
| Risk Grade | C+ |
| Value Grade | C+ |
Value Accrual: Does the Centrifuge Token Capture Value?
Centrifuge scores C+ on Hindenrank's value accrual framework (53/100), indicating average value capture — some strengths offset by weaknesses in fee distribution or sustainability. Fee capture scores 11/25 — moderate, with some fees reaching token holders but room for improvement. Token distribution is rated 6/25 (significantly concentrated among insiders or early investors), and emission sustainability sits at 16/25. The competitive moat dimension scores 20/25.
Protocol Health: Is Centrifuge Still Growing?
Centrifuge's vitality risk score is 3/10 on Hindenrank's rubric (lower is healthier). This indicates strong protocol health — active development, growing TVL, and an engaged community. Centrifuge shows signs of a thriving ecosystem that continues to attract users and developers.
Risk-Adjusted View: Is the Upside Worth the Risk?
Risk-Adjusted Position
NeutralCentrifuge sits in the Neutral zone — average on both risk (C+) and value (C+). There is no strong reason to overweight or avoid the token at current levels. Monitor for catalysts that could shift the balance in either direction.
Risk Context
Centrifuge carries a risk grade of C+ (36/100), classified as elevated risk — multiple novel mechanisms and notable interaction risks. While no critical-severity interactions were identified, 2 high-severity interactions warrant attention. The primary risk factor is: Real-world asset counterparty and default risk is inherently opaque on-chain; 2023 default event exposed originator vetting weaknesses
Read our full safety analysis →Where Centrifuge Sits Among RWA Peers
On risk, Centrifuge ranks #33 of 73 RWA protocols (above-median). That's in line with the sector average (38/100).
The closest peer by risk profile is BackedFi (grade C+, 36/100). See the side-by-side comparison to weigh their tradeoffs.
Should you buy Centrifuge?
Centrifuge scores C+ on Hindenrank's value accrual framework, placing it among the average RWA protocols. Fee capture scores 11/25 — moderate, with some fees reaching token holders but room for improvement. Token distribution is significantly concentrated among insiders or early investors, and emission sustainability sits at 16/25. On the risk side, Centrifuge carries a C+ grade (36/100), which is elevated risk — multiple novel mechanisms and notable interaction risks. The combined risk-value position places Centrifuge in the Neutral quadrant.
Centrifuge investment outlook for 2026
With $1.4B in total value locked and FDV of $190M, giving a TVL/FDV ratio of 7.36, Centrifuge's fundamentals do not strongly support the current valuation from a usage perspective. The competitive moat dimension scores 20/25, suggesting durable structural advantages that are difficult for competitors to replicate.Investors should weigh these fundamentals alongside market conditions and their own risk tolerance.
This analysis is based on cryptoeconomic fundamentals, not price prediction. It is not financial advice. Full methodology
Weekly Commentary
ProWeek of May 23, 2026
Centrifuge occupies a precarious position: technically sound but fundamentally stagnant. The Risk B- grade (35/100) reflects solid cryptoeconomic design, and the TVL/FDV ratio of 7.92 signals healthy collateral backing—there's real value underlying the token. Yet the Vitality score of 2/10 is a code red. This isn't a protocol gaining traction; it's a protocol treading water. The RWA thesis is structurally sound, but Centrifuge's execution has flatlined. Developer activity is minimal, TVL growth has stalled, and community engagement is dormant. When a protocol sits in the Safe but Stale quadrant, safety alone doesn't justify holding. The Value C+ grade (53/100) masks serious structural problems in token economics. Fee capture is anemic at 11/25—the protocol isn't effectively accruing value to CFG holders despite managing $1.5B in TVL. Token distribution is abysmal at 6/25, a catastrophic score that suggests either heavy early-stage concentration or problematic vesting schedules strangling the treasury and ecosystem participants. Emission Sustainability at 16/25 is middling; the protocol is burning cash without proportional revenue growth. The only bright spot is Competitive Moat at 20/25, which is genuine—real-world asset tokenization is defensible, and Centrifuge has first-mover advantage. But a strong moat can't carry a broken token model. Value accrual flows to vault operators and lenders, not token holders. What to watch: any announcements on fee restructuring or governance changes that might redirect cashflows to CFG stakers. Monitor whether this Vitality trajectory inflects upward—if it stays below 3/10 for another month, Centrifuge is signaling organizational burnout rather than strategic patience. The FDV/TVL disconnect (7.92x) is a warning. The protocol's TVL is real, but the token's valuation assumes future growth that the vitality metrics don't support. This is a hold-and-hope trade, not a conviction buy. For value investors, Centrifuge works only if you believe the RWA market explodes and the team can pivot from engineering to go-to-market. Until then, it's a collateral play, not an equity play.
Exploring options?
Compare RWA Alternatives →Related RWA Investment Analyses
Related RWA Safety Analyses
Get risk alerts before it's too late
Weekly grade changes, downgrade alerts, and new protocol risk findings. Free.